Phase III intergroup study of lenalidomide (CC-5013) versus placebo maintenance therapy following single autologous stem cell transplant for multiple myeloma (CALGB 100104): Initial report of patient accrual and adverse events Meeting Abstract
| Authors: | McCarthy, P. L.; Owzar, K.; Stadtmauer, E. A.; Giralt, S.; Hurd, D. D.; Hassoun, H.; Hofmeister, C.; Richardson, P.; Weisdorf, D. J.; Pasquini, M. C.; Hars, V.; Kelly, M.; Postiglione, J.; Sutherland, S.; Anderson, K. C.; Linker, C. |
| Abstract Title: | Phase III intergroup study of lenalidomide (CC-5013) versus placebo maintenance therapy following single autologous stem cell transplant for multiple myeloma (CALGB 100104): Initial report of patient accrual and adverse events |
| Meeting Title: | 51st Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 114 |
| Issue: | 22 |
| Meeting Dates: | 2009 Dec 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2009-11-20 |
| Start Page: | 1327 |
| Language: | English |
| ACCESSION: | WOS:000272725804081 |
| PROVIDER: | wos |
| PUBMED: | 22276299 |
| DOI: | 10.1182/blood.V114.22.3416.3416 |
| Notes: | Meeting Abstract: 3416 -- Source: Wos |
